Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has shared an announcement.
Shandong Xinhua Pharmaceutical Company Limited has announced a board meeting scheduled for August 26, 2025, to consider and approve the unaudited interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its strategic decisions moving forward.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China, primarily engaged in the pharmaceutical industry. The company focuses on the production and distribution of pharmaceutical products and is positioned within the healthcare sector.
Average Trading Volume: 10,122,753
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.68B
For an in-depth examination of 0719 stock, go to TipRanks’ Overview page.